Results 151 to 160 of about 15,396 (182)

Impact of Conjugate Pneumococcal Vaccines

Pediatric Infectious Disease Journal, 2005
openaire   +2 more sources

Pneumococcal-10-valent-vaccine-conjugate/pneumococcal-13-valent-crm197-vaccine-conjugate/pneumococcal-vaccine

Reactions Weekly, 2023
openaire   +1 more source

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

Lancet, The, 2006
Mónica M Farley, William Schaffner, Allen S Craig   +2 more
exaly  

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

Lancet, The, 2003
Ger T Rijkers, Anne G M Schilder
exaly  

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

Vaccine, 2013
Kathrin U Jansen, Daniel A Scott, Emilio A Emini   +2 more
exaly  

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Human Vaccines and Immunotherapeutics, 2019
Helen L Stacey, Luwy Musey
exaly  

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

Lancet, The, 2005
S K Obaro, Keith P W J Mcadam, Richard A Adegbola   +2 more
exaly  

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine

Expert Review of Vaccines, 2009
Ener Çagri Dinleyici
exaly  

Conjugate pneumococcal vaccine

Inpharma Weekly, 1998
openaire   +1 more source

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age

Vaccine, 2014
Richard N Greenberg, Robert W Frenck, James Trammel   +2 more
exaly